top of page
230721_상트네어-web_illust_technology.jpg

Platform Technology

Restructured monoclonal antibody with optimally enhanced FcγR avidity

competing platforms_01_3x.png

Antibody

T cell engager

ADC

CAR-T

Competing platforms

pipe_L_3x.png
container_L_3x.png

Low Efficacy

High Combinability

High Safety

pipe_R_3x.png
container_R_3x.png

Low Safety

Low Combinability

High Efficacy

CTN mab_3x.png

Our Twin Fc-ICE platform aims to overcome poor

efficacy of antibody drugs in treating cancer as well

as to achieve superior safety to ADC and CAR-T

Twin Fc-ICE

EFFICACY

SAFETY & COMBINABILITY

A simplified view of
Twin Fc-ICE’s MoA

PA_illust_3x.png

Enhanced Fc

effector functions

Macrophage

Dendritic cell

NK cell

Twin Fc-ICE

Cancer Cells

bottom of page